On Assignment (ASGN) is a professional staffing firm.
The company provides flexible and permanent staffing solutions in the United States, Europe, Canada, Australia, and New Zealand. The companys Life Sciences segment provides contract and permanent life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, personal care, chemical, medical device, automotive, municipal, education, and environmental industries.
Its contract professionals include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, biostatisticians, drug safety specialists, SAS programmers, medical writers, food scientists, regulatory affairs specialists, lab assistants, and other skilled scientific professionals.
The companys Healthcare segment offers locally-based and traveling contract professionals that include nurses, specialty nurses, respiratory therapists, surgical technicians, imaging technicians, X-ray technicians, medical technologists, medical assistants, pharmacists, pharmacy technicians, respiratory therapists, phlebotomists, coders, billers, claims processors, and collections staff, as well as dental professionals. This segment serves hospitals, integrated delivery systems, imaging centers, clinics, physician offices, reference laboratories, universities, managed care organizations, and third-party administrators.
Its Physician segment provides short and long-term locum tenens services, and full-service physician search and consulting services. The companys IT and Engineering segment offers high-end contract and direct placement services of information technology and engineering professionals with expertise in specialized information technology; software and hardware engineering; and mechanical, electrical, validation, and telecommunications engineering fields.
Shares have formed a bullish "flag" and are ready to move higher out of this formation.
52-Week Trading Range: $10.85 to $24.58
Entry Point: $23.30
Stop Loss: $21.85
Target Price: $25.50
We closed ASGN position at $24.80, for a profit of 6.5%, that was less than the 10% expected but our 30-day time limit had reached. A 6.5% gains was also a decent profit!